150 related articles for article (PubMed ID: 34532341)
1. Prognostic Immunity and Therapeutic Sensitivity Analyses Based on Differential Genomic Instability-Associated LncRNAs in Left- and Right-Sided Colon Adenocarcinoma.
Guo JN; Xia TY; Deng SH; Xue WN; Cui BB; Liu YL
Front Mol Biosci; 2021; 8():668888. PubMed ID: 34532341
[No Abstract] [Full Text] [Related]
2. Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma.
Guo JN; Li MQ; Deng SH; Chen C; Ni Y; Cui BB; Liu YL
Front Oncol; 2021; 11():640196. PubMed ID: 33763372
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.
Guo JN; Chen D; Deng SH; Huang JR; Song JX; Li XY; Cui BB; Liu YL
Cancer Immunol Immunother; 2022 Jun; 71(6):1313-1330. PubMed ID: 34657172
[TBL] [Abstract][Full Text] [Related]
4. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
Front Genet; 2021; 12():706661. PubMed ID: 34712264
[No Abstract] [Full Text] [Related]
5. Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas.
Li S; Chen Y; Guo Y; Xu J; Wang X; Ning W; Ma L; Qu Y; Zhang M; Zhang H
PeerJ; 2023; 11():e15810. PubMed ID: 37547724
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer.
Liu J; Cui G; Ye J; Wang Y; Wang C; Bai J
Front Cell Dev Biol; 2022; 10():753957. PubMed ID: 35433686
[No Abstract] [Full Text] [Related]
7. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma.
Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z
Front Genet; 2022; 13():874673. PubMed ID: 35547247
[No Abstract] [Full Text] [Related]
8. Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma.
Cao Y; Zhu H; Liu W; Wang L; Yin W; Tan J; Zhou Q; Xin Z; Huang H; Xie D; Zhao M; Jiang X; Peng J; Ren C
Front Genet; 2021; 12():758596. PubMed ID: 35069679
[No Abstract] [Full Text] [Related]
9. Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas.
Maimaiti A; Aili Y; Turhon M; Kadeer K; Aikelamu P; Wang Z; Niu W; Aisha M; Kasimu M; Wang Y; Wang Z
Front Mol Biosci; 2022; 9():844973. PubMed ID: 35359593
[No Abstract] [Full Text] [Related]
10. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.
Fang X; Liu X; Lu L; Liu G
Front Oncol; 2021; 11():728181. PubMed ID: 34676164
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer.
Sun J; Jiang Q; Chen H; Zhang Q; Zhao J; Li H; Wang X; Fang Y; Ruan Y; Sun Y
Ann Transl Med; 2021 Aug; 9(16):1326. PubMed ID: 34532463
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer.
Yin T; Zhao D; Yao S
Front Genet; 2021; 12():679150. PubMed ID: 34163531
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis and validation of lncRNAs in bladder cancer on the basis of neutrophil extracellular traps.
Gu L; Guo H; Wu LX; Yuan JB
J Gene Med; 2023 Oct; 25(10):e3525. PubMed ID: 37178049
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer.
Zhang HC; Deng SH; Pi YN; Guo JN; Xi H; Shi X; Yang XF; Zhang BM; Xue WN; Cui BB; Liu YL
Front Immunol; 2022; 13():855849. PubMed ID: 35444656
[TBL] [Abstract][Full Text] [Related]
19. Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer.
Chen S; Li X; Zhang J; Li L; Wang X; Zhu Y; Guo L; Wang J
J Gastrointest Oncol; 2021 Oct; 12(5):2157-2171. PubMed ID: 34790382
[TBL] [Abstract][Full Text] [Related]
20. Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
Zhou W; Zhang S; Li HB; Cai Z; Tang S; Chen LX; Lang JY; Chen Z; Chen XL
Biomed Res Int; 2020; 2020():9807918. PubMed ID: 32964050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
